Adare Pharma Solutions To Expand Packaging & Warehousing Capabilities In Europe

LAWRENCEVILLE, NJ, March 5, 2024 — Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced that work has begun to add packaging capabilities and further warehousing capacity at its Pessano facility in Milan, Italy.

The two-story 2,800 square-meter extension at the site will accommodate a new packaging line in a purpose-built packaging hall. The Marchesini Integra 220S MA260 packaging line will primarily be used to package tablets and capsules into Aclar, Triplex, PVC, PVDC, ALU/ALU blisters. The machine features integrated Robocombi ‘pick and place’ and serialization capabilities, and is capable of packaging more than 50 million blisters annually. The new packaging line is projected to be installed by Q4 2024.

The expansion to the Pessano site also includes an additional 1,000 square-meter warehouse with capacity for 900 pallets, as well as space to accommodate a second packaging line for future needs.

“The addition of a new state-of-the-art packaging line and high-capacity warehouse expands on the comprehensive CDMO solutions Adare provides customers in Europe, the United States, and Asia,” said Tom Sellig, CEO of Adare Pharma Solutions.

The 20,400 square meter Pessano facility provides R&D services to expedite formulation and process development, with a seamless integrated transition to manufacturing. It is capable of manufacturing a wide range of solid dosage forms at both clinical and commercial scales, including granules, capsules, and tablets. The facility also provides controlled substance and organic solvent capabilities.

---

About Adare Pharma Solutions
Adare Pharma Solutions is a global technology-driven contract development and manufacturing organization (CDMO) providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms for the Pharmaceutical industry. Adare’s specialized technology platforms provide taste masking, customized release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare’s seven facilities in the US and Europe have developed and manufactured more than 65 products sold by customers worldwide. Learn more at www.adare.coaxcloud.com.